Moreover, in acute myeloid leukemia (AML) cells, METTL3 was abundantly expressed and promoted MYC, BCL2, and PTEN translation through m6A modification, which inhibited cell differentiation and fueled leukemia progression16. Here, MYC is linked to acute myeloid leukemia.